Related references
Note: Only part of the references are listed.Impact of Routine Unilateral Central Neck Dissection on Preablative and Postablative Stimulated Thyroglobulin Levels after Total Thyroidectomy in Papillary Thyroid Carcinoma
Brian Hung-Hin Lang et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Impact on Overall Survival of Radioactive Iodine in Low-Risk Differentiated Thyroid Cancer Patients
Claire Schvartz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
American Thyroid Association Design and Feasibility of a Prospective Randomized Controlled Trial of Prophylactic Central Lymph Node Dissection for Papillary Thyroid Carcinoma
Tobias Carling et al.
THYROID (2012)
Evaluation of Postoperative Radioactive Iodine Scans in Patients who Underwent Prophylactic Central Lymph Node Dissection
Amanda M. Laird et al.
WORLD JOURNAL OF SURGERY (2012)
Clinical and Molecular Features of Papillary Thyroid Cancer in Adolescents and Young Adults
Menno R. Vriens et al.
CANCER (2011)
Psychological, Social, and Behavioral Issues for Young Adults With Cancer
Brad J. Zebrack
CANCER (2011)
Rising Incidence of Second Cancers in Patients With Low-Risk (T1N0) Thyroid Cancer Who Receive Radioactive Iodine Therapy
N. Gopalakrishna Iyer et al.
CANCER (2011)
SEOM clinical guidelines for the treatment of thyroid cancer
Javier Martinez Trufero et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2011)
Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer
F. Vaisman et al.
CLINICAL ENDOCRINOLOGY (2011)
Incidence of Second Primary Malignancies During a Long-term Surveillance of Patients With Differentiated Thyroid Carcinoma in Relation to Radioiodine Treatment
Babak Fallahi et al.
CLINICAL NUCLEAR MEDICINE (2011)
Use of Radioactive Iodine for Thyroid Cancer
Megan R. Haymart et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Effects of different doses of radioactive iodine for remnant ablation on successful ablation and on long-term recurrences in patients with differentiated thyroid carcinoma
Eui Young Kim et al.
NUCLEAR MEDICINE COMMUNICATIONS (2011)
Prognostic Impact of Serum Thyroglobulin Doubling-Time Under Thyrotropin Suppression in Patients with Papillary Thyroid Carcinoma Who Underwent Total Thyroidectomy
Akira Miyauchi et al.
THYROID (2011)
Prophylactic Central Neck Dissection and Local Recurrence in Papillary Thyroid Cancer: A Meta-analysis
Tarek Zetoune et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Contemporary Post Surgical Management of Differentiated Thyroid Carcinoma
H. Tala et al.
CLINICAL ONCOLOGY (2010)
Thyroid Carcinoma
R. Michael Tuttle et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2010)
A usability study of a computerized decision aid to help patients with, early stage papillary thyroid carcinoma in, decision-making on adjuvant radioactive iodine treatment
Anna M. Sawka et al.
PATIENT EDUCATION AND COUNSELING (2010)
Impact of second primary malignancy on outcomes of differentiated thyroid carcinoma
Brian Hung-Hin Lang et al.
SURGERY (2010)
Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer
David T. Hughes et al.
SURGERY (2010)
Radioactive Iodine Administered for Thyroid Remnant Ablation Following Recombinant Human Thyroid Stimulating Hormone Preparation Also Has an Important Adjuvant Therapy Function
R. Michael Tuttle et al.
THYROID (2010)
Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer a - randomized controlled trial
Anna M. Sawka et al.
TRIALS (2010)
Recombinant Thyrotropin Use in Children and Adolescents with Differentiated Thyroid Cancer: A Multicenter Retrospective Study
Markus Luster et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Prophylactic Lymph Node Dissection for Papillary Thyroid Cancer Less Than 2 cm: Implications for Radioiodine Treatment
Stephane Bonnet et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
The Benefits and Risks of I-131 Therapy in Patients with Well-Differentiated Thyroid Cancer
Douglas Van Nostrand
THYROID (2009)
Second Primary Malignancy Risk After Radioactive Iodine Treatment for Thyroid Cancer: A Systematic Review and Meta-analysis
Anna M. Sawka et al.
THYROID (2009)
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
David S. Cooper et al.
THYROID (2009)
Selective Surgical Management of Well-Differentiated Thyroid Cancer
Ashok Shaha
RECENT ADVANCES IN CLINICAL ONCOLOGY (2008)
The HiLo trial: A multicentre randomised trial of high- versus low-dose radioiodine, with or without recombinant human thyroid stimulating hormone, for remnant ablation after surgery for differentiated thyroid cancer
U. Mallick et al.
CLINICAL ONCOLOGY (2008)
The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer
Aaron. P. Brown et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Quality of life in cured patients with differentiated thyroid carcinoma
Hendrieke C. Hoftijzer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Low vs. High Radioiodine Activity to Ablate the Thyroid after Thyroidectomy for Cancer: A Randomized Study
Hanna O. Maenpaa et al.
PLOS ONE (2008)
Regional differences in opinions on adjuvant radioactive iodine treatment of thyroid carcinoma within Canada and the United States
Anna M. Sawka et al.
THYROID (2007)
Extent of surgery affects survival for papillary thyroid cancer
Karl Y. Bilimoria et al.
ANNALS OF SURGERY (2007)
Survival in patients with papillary thyroid cancer is not affected by the use of radioactive isotope
Yale D. Podnos et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
Papillary thyroid carcinoma: 35-year outcome and prognostic factors in 1858 patients
Maria Rosa Pelizzo et al.
CLINICAL NUCLEAR MEDICINE (2007)
Influence of surgical and postoperative treatment on survival in differentiated thyroid cancer
C. I. Lundgren et al.
BRITISH JOURNAL OF SURGERY (2007)
Review: I-131 activity for remnant ablation in patients with differentiated thyroid cancer: A systematic review
Allan Hackshaw et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Selective use of radioactive iodine in the postoperative management of patients with papillary and follicular thyroid carcinoma
Ian D. Hay
JOURNAL OF SURGICAL ONCOLOGY (2006)
Outcomes of patients with differentiated thyroid carcinoma following initial therapy
Jacqueline Jonklaas et al.
THYROID (2006)
Second primary cancers in thyroid cancer patients:: A multinational record linkage study
TC Sandeep et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Risk of second primary malignancies in women with papillary thyroid cancer
AJ Canchola et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: Results of an international, randomized, controlled study
F Pacini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review
B Jarzab et al.
ENDOCRINE-RELATED CANCER (2005)
Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation:: a consensus report
F Pacini et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years
J Brierley et al.
CLINICAL ENDOCRINOLOGY (2005)
A case-controlled study on the quality of life in a cohort of patients with history of differentiated thyroid carcinoma
M Giusti et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2005)
Thyroglobulin assay 4 weeks after thyroidectomy predicts outcome in low-risk papillary thyroid carcinoma
L Giovanella et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2005)
Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: A randomized clinical trial in 509 patients
CS Bal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Predicting outcome and directing therapy for papillary thyroid carcinoma
S Kim et al.
ARCHIVES OF SURGERY (2004)
Differentiated thyroid carcinoma in childhood and adolescence-clinical course and role of radioiodine
SM Chow et al.
PEDIATRIC BLOOD & CANCER (2004)
Current strategies for surgical management and adjuvant treatment of childhood papillary thyroid carcinoma
GB Thompson
WORLD JOURNAL OF SURGERY (2004)
Risk of second primary cancer following differentiated thyroid cancer
E Berthe et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
Second primary malignancies in thyroid cancer patients
C Rubino et al.
BRITISH JOURNAL OF CANCER (2003)
Who performs endocrine operations in the United States?
BD Saunders et al.
SURGERY (2003)
Long-term impairment of the lacrimal glands after radioiodine therapy: a cross-sectional study
G Zettinig et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2002)
Ablation of thyroid residues with 30 mCi 131I:: A comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal
F Pacini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): Temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients
ID Hay et al.
WORLD JOURNAL OF SURGERY (2002)
Papillary thyroid carcinoma: Prognostic factors and the role of radioiodine and external radiotherapy
SM Chow et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Current practice of radioiodine treatment in the management of differentiated thyroid cancer in Germany
S Hoelzer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2000)
Differentiated thyroid cancer: Clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group
MP La Quaglia et al.
JOURNAL OF PEDIATRIC SURGERY (2000)